NPS Pharmaceuticals, Inc. (NPSP) Posts Q3 Loss of 4c/Share
Tweet
Share
E-mailGet Alerts NPSP Hot Sheet
Price: $45.97 --0%
Financial Fact:
Research and development: 24.53M
Today's EPS Names:
VAXX, NMRD, AFIB, More
Financial Fact:
Research and development: 24.53M
Today's EPS Names:
VAXX, NMRD, AFIB, More
Join SI Premium – FREE
NPS Pharmaceuticals, Inc. (NASDAQ: NPSP) reported Q3 EPS of ($0.04), $0.12 better than the analyst estimate of ($0.16). Revenue for the quarter came in at $27.02 million versus the consensus estimate of $28.18 million.
For earnings history and earnings-related data on NPS Pharmaceuticals, Inc. (NPSP) click here.
For earnings history and earnings-related data on NPS Pharmaceuticals, Inc. (NPSP) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Netflix climbs following Ackman stake, up 1.8%
- Buda Juice, Inc. (BUDA) Reports Q2 EPS of $0.04
- Nomad Foods Limited (NOMD) Tops Q2 EPS by 6c; offers guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
